Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2023 0 · FY2024 90 — 2-yr total 90
Abulpharm LLC is a Tbilisi-based pharmaceutical distributor and wholesaler set up with Turkish investment (~USD 2m), operating a pharmaceutical warehouse in the Gldani industrial zone with regional export activity, particularly to Russia.
| Ratio | 2023 | 2024 |
|---|---|---|
| Margins | ||
| Gross Margin | 37.4% | 52.6% |
| EBITDA Margin | 36.0% | 52.7% |
| EBITDAR | 48,381 | 179,946 |
| EBITDAR Margin | 36.0% | 52.7% |
| EBIT Margin | 36.0% | 52.7% |
| Net Profit Margin | 36.0% | 52.7% |
| Operating Expense % of Sales | 1.4% | 2.0% |
| Returns | ||
| Return on Assets (ROA) | 35.4% | 48.3% |
| Return on Equity (ROE) | 97.4% | 75.8% |
| ROIC [EBIT / Invested Capital] | 98.2% | 78.8% |
| Leverage & debt balances | ||
| Debt-to-Assets | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x |
| Equity-to-Assets | 36.3% | 63.7% |
| Net Debt | -404 | -9,029 |
| Cash & Equivalents | 404 | 9,029 |
| Total Debt | N/A | N/A |
| Liquidity & working capital | ||
| Current Ratio | 1.57x | 2.75x |
| Quick Ratio | 1.55x | 2.72x |
| Cash Ratio | 0.00x | 0.07x |
| Total Current Assets | 136,815 | 372,077 |
| Total Current Liabilities | 87,158 | 135,495 |
| Inventory | 1,667 | 3,180 |
| Trade Receivables | 134,744 | 359,868 |
| Trade Payables | 87,158 | 135,223 |
| Net Working Capital | 49,657 | 236,582 |
| Net Working Capital % of Revenue | 37.0% | 69.3% |
| Trade Working Capital | 49,253 | 227,825 |
| Trade Working Capital % of Revenue | 36.7% | 66.8% |
| Change in Trade Working Capital | N/A | 178,572 |
| Turnover & efficiency | ||
| Inventory Turnover | 50.40x | 50.82x |
| Days Inventory Outstanding (DIO) | 7.2 | 7.2 |
| Receivables Turnover | 1.00x | 0.95x |
| Days Sales Outstanding (DSO) | 366.3 | 384.9 |
| Payables Turnover | 0.96x | 1.20x |
| Days Payable Outstanding (DPO) | 378.7 | 305.4 |
| Cash Conversion Cycle | -5.1 days | 86.7 days |
| Asset Turnover | 0.98x | 0.92x |
| Cash flow & dividends | ||
| Operating Cash Flow | 343 | 431 |
| Free Cash Flow (OCF − Capex proxy) | 343 | -358 |
| Cash Conversion (OCF / EBITDA) | 0.7% | 0.2% |
| Dividends Declared | 0 | 90 |
| Dividend Payout Ratio | 0.0% | 0.1% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →